We are live on ! Find out more
PYXS icon

Pyxis Oncology

71 hedge funds and large institutions have $97.7M invested in Pyxis Oncology in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,168% more capital inflows, than outflows

Capital inflows: $63.9M | Capital outflows: $2.82M

320% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 5

233% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 9

167% more call options, than puts

Call options by funds: $543K | Put options by funds: $203K

39% more funds holding

Funds holding: 51 → 71 (+20)

19.6% more ownership

Funds ownership: 19.85% → 39.44% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
71
Holders Change
+20
Holders Change %
+39.22%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
21
Reduced
5
Closed
9
Calls
$543​K
Puts
$203​K
Net Calls
+$340​K
Net Calls Change
+$318​K

PYXS Hedge Fund Activity: Q1 2024 in Review

71 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q1 2024, worth a combined $97.7M — up 517% from $15.8M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new PYXS positions and 9 closed out — a net gain of 21 holders — while 21 added to existing stakes and 5 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $17.6M. The largest seller was Renaissance Technologies, cutting an estimated $909K.

  • 71 institutional investors held Pyxis Oncology (PYXS) as of Q1 2024, up from 51 in Q4 2023.
  • Funds reported $97.7M of Pyxis Oncology stock for Q1 2024, up 517% quarter-over-quarter.
  • 30 funds opened new Pyxis Oncology positions in Q1 2024 and 9 closed out, a net change of +21 holders.
  • The largest Pyxis Oncology buyer in Q1 2024 was Deep Track Capital, an estimated $17.6M added.
  • The largest Pyxis Oncology seller in Q1 2024 was Renaissance Technologies, an estimated $909K sold.

Based on aggregated 13F filings for Q1 2024.